Arabic Arabic English English French French German German
dark

Pfizer-BioNTech COVID-19 vaccine safe, effective in cancer patients

(HealthDay)—The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine (Pfizer-BioNTech) appears to be safe and achieves satisfactory serologic status in patients with cancer, according to a study published online July 8 in JAMA Oncology. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Israeli Startup Aidoc Raises $65M for AI-Powered Medical Imaging Platform

Next Post

Average soda fountain serving exceeds daily recommended added sugars

Related Posts
Total
0
Share